NYSE:HYH - Halyard Health Stock Price, Price Target & More

Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH."

Halyard Health (NYSE:HYH) released its quarterly earnings results on Wednesday, May, 2nd. The medical instruments supplier reported $0.76 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.17 by $0.59. The medical instruments supplier had revenue of $156.40 million for the quarter, compared to analyst estimates of $155.08 million. Halyard Health had a net margin of 7.72% and a return on equity of 7.90%. The firm's revenue was up 7.3% on a year-over-year basis. During the same quarter last year, the business earned $0.48 earnings per share. View Halyard Health's Earnings History.

Halyard Health updated its FY18 earnings guidance on Wednesday, May, 2nd. The company provided EPS guidance of $1.65-$1.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.26.

5 analysts have issued twelve-month price targets for Halyard Health's shares. Their predictions range from $50.00 to $62.00. On average, they anticipate Halyard Health's share price to reach $55.50 in the next twelve months. View Analyst Ratings for Halyard Health.

Some companies that are related to Halyard Health include William Demant (WILYY), STERIS (STE), Inogen (INGN), Mine Safety Appliances (MSA), Wright Medical Group (WMGI), Consort Medical (CSRMY), Invacare (IVC), Sientra (SIEN), RTI Surgical (RTIX), Lakeland Industries (LAKE), ConforMIS (CFMS), Histogenics (HSGX), Rewalk Robotics (RWLK), NanoVibronix (NAOV) and Helomics (AIPT).

Media headlines about HYH stock have been trending somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Halyard Health earned a coverage optimism score of 0.21 on Accern's scale. They also assigned media headlines about the medical instruments supplier an impact score of 47.67 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term.

Halyard Health's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.62%), Dimensional Fund Advisors LP (7.28%), Paradice Investment Management LLC (3.30%), Northern Trust Corp (3.23%), Champlain Investment Partners LLC (1.60%) and Prudential Financial Inc. (1.03%). View Institutional Ownership Trends for Halyard Health.

HYH stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Prudential Financial Inc., Chicago Equity Partners LLC, Schwab Charles Investment Management Inc., Wells Fargo & Company MN, Spark Investment Management LLC, Citigroup Inc. and Russell Investments Group Ltd.. View Insider Buying and Selling for Halyard Health.

HYH stock was purchased by a variety of institutional investors in the last quarter, including Champlain Investment Partners LLC, Select Equity Group L.P., Great West Life Assurance Co. Can, New York State Common Retirement Fund, Lord Abbett & CO. LLC, Millennium Management LLC, BlackRock Inc. and Great Lakes Advisors LLC. View Insider Buying and Selling for Halyard Health.

Shares of HYH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of HYH stock can currently be purchased for approximately $53.47.

Halyard Health has a market capitalization of $2.52 billion and generates $611.60 million in revenue each year. The medical instruments supplier earns $79.30 million in net income (profit) each year or $2.35 on an earnings per share basis. Halyard Health employs 13,000 workers across the globe.

Halyard Health's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The medical instruments supplier can be reached via phone at 678-425-9273 or via email at [email protected]